Product Name: Clindamycin phosphate
Synonyms: indamycin phosphate;(2s-trans)-;2-(dihydrogenphosphate;U-28508E;methyl (2S-trans)-7-chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-L-threo-alpha-D-galacto-octopyranoside, 2-(dihydrogen phosphate);Clindamycin phosphate BP98,USP25,EP97;Clindaymcin Palmitate hydrochloride USP23;L-threo-.alpha.-D-galacto-Octopyranoside, methyl 7-chloro-6,7,8-trideoxy-6-(2S,4R)-1-methyl-4-propyl-2-pyrrolidinylcarbonylamino-1-thio-, 2-(dihydrogen phosphate)
CAS: 24729-96-2
MF: C18H34ClN2O8PS
MW: 504.97
EINECS: 246-433-0
Product Categories: Antibiotics for Research and Experimental Use;Biochemistry;Others (Antibiotics for Research and Experimental Use);API's;Intermediates & Fine Chemicals;Pharmaceuticals
Mol File: 24729-96-2.mol
Clindamycin phosphate Structure
Clindamycin phosphate Chemical Properties
Melting point 114 °C
Boiling point 159°C
density 1.41±0.1 g/cm3(Predicted)
refractive index 122 ° (C=1, H2O)
storage temp. 2-8°C
solubility DMSO: soluble224mg/mL at 25°C
form solid
pka pKa 0.964±0.06 (H2O t=21) (Uncertain);6.06 ±0.06 (I=0.008)(H2O t=21) (Uncertain)
Water Solubility Freely soluble in water
Merck 14,2356
Stability: Stable, but store cool. Incompatible with strong oxidizing agents, calcium gluconate, barbiturates, magnesium sulfate, phenytoin, B group sodium vitamins.
Safety Information
Hazard Codes Xn,Xi
Risk Statements 22-36/37/38
Safety Statements 36-26
WGK Germany 3
RTECS GF2625000
HS Code 29419000